The findings show that prolonged targeted therapy in patients with head and neck cancer can heighten tumor alertness, ...

CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...